Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations - Université des Antilles Access content directly
Journal Articles Journal of Investigative Dermatology Year : 2021

Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations

Jean-David Bouaziz
Eric Fontas
Pascal Reygagne
Marie-Aleth Richard
Fichier principal
Vignette du fichier
S0022202X20320509.pdf (917.29 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03338969 , version 1 (22-03-2023)

Licence

Identifiers

Cite

Florence Le Duff, Jean-David Bouaziz, Eric Fontas, Michel Ticchioni, Manuelle Viguier, et al.. Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations. Journal of Investigative Dermatology, 2021, 141 (4), pp.933 - 936.e6. ⟨10.1016/j.jid.2020.08.015⟩. ⟨hal-03338969⟩
32 View
28 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More